Termination of the technology licensing agreement with Immunomic Therapeutics for Japanese cedar pollen allergy vaccine technology
Specific matter concerning the termination of the technology licensing agreement for a Japanese cedar pollen allergy treatment vaccine technology licensed in from Immunomic Therapeutics, Inc.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.